Cepheid's Solution to Healthcare-Associated Infections

PCR Testing With Easy & Standardized Workflows

 
HAI hospital associated infections and critical infections cartridge

Confident Answers for Healthcare-Associated Infectious (HAI) Diseases

Rapid, accurate PCR testing to support clinical decision making across the hospital.

PCR Testing Designed for Infection Prevention & Control:

Healthcare‑associated infections demand speed, accuracy, and reliability—yet traditional diagnostic workflows can delay results, limit outbreak visibility, and strain lab resources. Cepheid combines on‑demand PCR technology, standardized workflows, and a broad infectious disease menu to help hospitals respond fast—without adding complexity.

 

Why hospitals choose Cepheid for HAI testing:

  • Fast, actionable results to support timely isolation and treatment decisions
  • Flexible placement across centralized and near‑patient settings

 

Available HAI tests from Cepheid: 

 

Xpert® GI Panel - Detection and identification of DNA and RNA from multiple bacteria, parasites and/or virus in around 74 minutes*

 

Xpert® C. difficile/Epi - detection of Clostridium difficile infection with an independent call-out of the 027 strain in around 45 minutes*

 

Xpert® MRSA NxG - detects methicillin-resistant Staphylococcus aureus (MRSA) directly from nasal swabs in around 70 minutes*

 

Xpert® SA Nasal Complete  - supports pre-surgical testing of S. aureus and MRSA in about an hour*

 

Xpert® MRSA/SA Blood Culture- detects MRSA and methicillin-susceptible Staphylococcus aureus (MSSA) in positive blood cultures in about an hour*

 

Xpert® MRSA/SA SSTI - detects MRSA and S. aureus skin and soft tissue infections in about an hour*

 

Xpert® Norovirus - provides highly accurate detection of Norovirus with results in as little as one hour*

 

Xpert® Carba-R - a qualitative and on-demand test for the detection and differentiation of carbapenem resistance of KPC, NDM, VIM, OXA-48, and IMP in 50 minutes*

 

Xpert® vanA- is the first rapid and accurate test to assist with vancomycin-resistant enterococci (VRE) surveillance in about 48 minutes*

 Learn More: 

Let’s Talk About Your HAI Testing Needs

Complete the form below to connect with a Cepheid representative and learn how our HAI portfolio can support your needs.

I would like to receive personalized information about products and services from Cepheid and other Danaher group companies as indicated below. I understand that my preferences and interactions, including whether I’ve opened your messages, will be used to personalize content to my interests. I can withdraw my consent at any time by contacting Privacy.officer@cepheid.com or by using the unsubscribe option in any email I receive. For more details I can review your Privacy Policy.​

Privacy - Terms

*required fields
Cepheid respects your privacy, and values the relationship with our customers, partners, and associates. Your personal data may be processed by Cepheid, its affiliates, representatives and other Danaher companies for business and marketing purposes. You can review Cepheid Privacy Policy online for additional information on your rights and how we use and share personal data we collect on our websites and other channels. Your consent to receiving Cepheid news can be withdrawn at any time. Building a relationship of trust is important to us and we will happily help with any questions on your personal data processing addressed to Privacy.officer@cepheid.com

A Look Inside Cepheid's Xpert GI Panel

Mike Chen, Ph.D., VP of Technology & Innovation at Cepheid, dives into the power of syndromic testing for acute gastroenteritis.

US-IVD. In Vitro Diagnostic Medical Device. May not be available in all countries.

*Turnaround times may vary by test. See individual product inserts for specific turnaround times.

About Cepheid

Cepheid is dedicated to improving healthcare by pioneering molecular diagnostics that combine speed, accuracy, and flexibility. The company's GeneXpert® systems and Xpert® tests automate highly complex and time-consuming manual procedures, providing A Better Way for institutions of any size to perform world-class PCR testing. Cepheid's broad test portfolio spans respiratory infections, blood virology, women's and sexual health, TB and emerging infectious diseases, healthcare-associated infectious diseases, oncology and human genetics. The company's solutions deliver actionable results where they are needed most from central laboratories and hospitals to near patient settings.

For more information, visit www.cepheid.com

904 Caribbean Drive, Sunnyvale, CA 94089

©2026 Cepheid. All Rights Reserved.